Ameriprise Financial Inc Intellia Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 31,180 shares of NTLA stock, worth $373,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,180

Previous 35,971 13.32%

Holding current value

$373,224

Previous $805,000 20.5%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.72 - $27.36 $94,478 - $131,081	-4,791 Reduced 13.32%	31,180 $640,000
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $77,097 - $104,824	3,851 Added 11.99%	35,971 $805,000
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $6.6 Million - $9.09 Million	-277,092 Reduced 89.61%	32,120 $883,000
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $6.39 Million - $8.92 Million	275,857 Added 827.03%	309,212 $9.43 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $524,955 - $760,039	16,602 Added 99.1%	33,355 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $9,198 - $12,243	266 Added 1.61%	16,753 $683,000
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $13.1 Million - $17.7 Million	-394,335 Reduced 95.99%	16,487 $614,000
Q4 2022 Feb 14, 2023	SELL	$33.21 - $62.69 $802,154 - $1.51 Million	-24,154 Reduced 5.55%	410,822 $14.3 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $1.12 Million - $1.49 Million	20,819 Added 5.03%	434,976 $24.3 Million
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $692,935 - $1.37 Million	-18,003 Reduced 4.17%	414,157 $21.4 Million
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $310,579 - $634,216	-5,330 Reduced 1.22%	432,160 $31.4 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $71,841 - $98,650	713 Added 0.16%	437,490 $51.7 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $29 Million - $38.8 Million	219,321 Added 100.86%	436,777 $58.6 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $12.3 Million - $32.8 Million	202,813 Added 1385.05%	217,456 $35.2 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $302,369 - $543,083	6,490 Added 79.6%	14,643 $1.22 Million
Q4 2020 Feb 12, 2021	BUY	$18.83 - $63.53 $153,520 - $517,960	8,153 New	8,153 $312,000
Q4 2019 Feb 14, 2020	SELL	$10.43 - $17.67 $117,660 - $199,335	-11,281 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$13.07 - $18.51 $308,059 - $436,280	-23,570 Reduced 67.63%	11,281 $150,000
Q2 2019 Aug 14, 2019	BUY	$13.88 - $18.41 $320,031 - $424,479	23,057 Added 195.5%	34,851 $570,000
Q1 2019 May 15, 2019	BUY	$12.79 - $17.62 $150,845 - $207,810	11,794 New	11,794 $202,000
Q4 2018 Feb 14, 2019	SELL	$11.39 - $27.13 $1.07 Million - $2.56 Million	-94,381 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$25.78 - $32.6 $248,519 - $314,264	-9,640 Reduced 9.27%	94,381 $2.7 Million
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $2.08 Million - $3.2 Million	104,021 New	104,021 $2.76 Million

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $910M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Intellia Therapeutics, Inc. Transaction History